These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 45285)

  • 61. Plasma catecholamines and cardiovascular responses to hypoglycemia in hyperthyroidism before and during treatment with metoprolol or propranolol.
    Nilsson OR; Karlberg BE; Söderberg A
    J Clin Endocrinol Metab; 1980 May; 50(5):906-11. PubMed ID: 6989845
    [No Abstract]   [Full Text] [Related]  

  • 62. Enhanced gluconeogenic capacity from glycerol in hyperthyroid man: evidence in favour of a beta-adrenergic mechanism.
    McCulloch AJ; Steele NR; Kendall-Taylor P; Baylis PH; Alberti KG
    Clin Endocrinol (Oxf); 1984 Oct; 21(4):399-407. PubMed ID: 6096044
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Reduction by propranolol of urinary hydroxyproline excretion in human hyperthyroidism: a beta-receptor blockade effect or a membrane stabilizing mechanism?
    Beylot M; Borson F; David L; Sautot G; Riou JP; Mornex R
    Metabolism; 1984 Feb; 33(2):124-8. PubMed ID: 6694555
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Acute factitious hyperthyroidism--moderate clinical symptoms in 3 cases under beta-blocker treatment].
    Keck FS; Loos U; Duntas L; Pfeiffer EF
    Klin Wochenschr; 1986 Apr; 64(7):319-26. PubMed ID: 3713106
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The heart and hyperthyroidism. Use of beta-adrenergic blocking drugs.
    Levey GS
    Med Clin North Am; 1975 Sep; 59(5):1193-9. PubMed ID: 240093
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Phonomecanographic study of 3 beta-blockers and d-propranolol in obstructive cardiomyopathy].
    Hitchitz S; Veyrat C; Gourtchiglouian M
    Therapie; 1978; 33(5):599-606. PubMed ID: 33466
    [No Abstract]   [Full Text] [Related]  

  • 67. Adrenergic beta receptor inhibition and hyperthyroidism.
    Malcolm J
    Acta Cardiol; 1972; ():Suppl 15:307-2. PubMed ID: 4147614
    [No Abstract]   [Full Text] [Related]  

  • 68. Beta-adrenoreceptor mechanisms in essential tremor: a comparative single dose study of the effect of a non-selective and a beta-2 selective adrenoreceptor antagonist.
    Cleeves L; Findley LJ
    J Neurol Neurosurg Psychiatry; 1984 Sep; 47(9):976-82. PubMed ID: 6148382
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Use of propranolol in thyrotoxicosis.
    Horowitz W; Canary JJ
    N Engl J Med; 1971 Feb; 284(6):333-4. PubMed ID: 4395388
    [No Abstract]   [Full Text] [Related]  

  • 70. Propranolol influences serum T3 and reverse T3 in hyperthyroidism.
    Theilade P; Hansen JM; Skovsted L; Faber J; Kirkegård C; Friis T; Siersbaek-Nielsen K
    Lancet; 1977 Aug; 2(8033):363. PubMed ID: 69976
    [No Abstract]   [Full Text] [Related]  

  • 71. Insulin release and carbohydrate tolerance in hyperthyroid patients during non-selective or selective beta-1-adrenoceptor blockade.
    Nilsson OR; Kågedal B; Tegler L
    Acta Endocrinol (Copenh); 1980 Feb; 93(2):179-85. PubMed ID: 6103627
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Propranolol as an adjunct therapy for hyperthyroid tremor.
    Henderson JM; Portmann L; Van Melle G; Haller E; Ghika JA
    Eur Neurol; 1997; 37(3):182-5. PubMed ID: 9137929
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Protein metabolism in skeletal muscle tissue from hyperthyroid patients after preoperative treatment with antithyroid drug or selective beta-blocking agent. Results from a prospective, randomized study.
    Hasselgren PO; Adlerberth A; Angerås U; Stenström G
    J Clin Endocrinol Metab; 1984 Nov; 59(5):835-9. PubMed ID: 6207197
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Hemodynamic study of hyperthyroidism and variations induced by propranolol].
    Cayuela ML; Doval H; Bazzino O; Hermberg HC
    Medicina (B Aires); 1977; 37(3):223-31. PubMed ID: 19677
    [No Abstract]   [Full Text] [Related]  

  • 75. Comparison of propranolol and Ro 3-3528 in hyperthyroid tachycardia and dysrhythmias.
    Phillips EM; Turner P; Houghton J; Ferriman DG
    Postgrad Med J; 1973 Jan; 49(567):18-23. PubMed ID: 4147246
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Beta-adrenergic blockade for the treatment of hyperthyroidism.
    Geffner DL; Hershman JM
    Am J Med; 1992 Jul; 93(1):61-8. PubMed ID: 1352658
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Oxygen consumption in patients with hyperthyroidism before and after treatment with beta-blockade versus thyrostatic treatment: a prospective randomized study.
    Jansson S; Lie-Karlsen K; Stenqvist O; Körner U; Lundholm K; Tisell LE
    Ann Surg; 2001 Jan; 233(1):60-4. PubMed ID: 11141226
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prolonged effect of nadolol on heart rate in hyperthyroidism.
    Adam RD; Parekh P; Harrower AD
    Curr Med Res Opin; 1981; 7(4):212-4. PubMed ID: 6112117
    [TBL] [Abstract][Full Text] [Related]  

  • 79. What is the real pharmacological rationale for beta-receptor blocking agents?
    Biamino G; Schröder R
    Eur Heart J; 1983 Jul; 4 Suppl D():137-41. PubMed ID: 6137373
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Investigation of the usefulness of the plasma adenosine 3' 5' - cyclic monophosphate response to glucagon in thyroid disease.
    Mac Neil S; Hendy GN; Amirrasooli H; Daggett PR; Tomlinson S
    J Endocrinol Invest; 1980; 3(4):401-4. PubMed ID: 6259251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.